When: Saturday, June 15, 10 a.m. – Noon
Where: River Crossing Park, 6635 Riverside Dr., Dublin, OH
What: Ask questions and discover the latest treatment options from the liver specialists and nationally ranked liver transplant experts at The Ohio State University Wexner Medical Center.
- First FDA-approved drug for MASH (metabolic dysfunction-associated steatohepatitis) is now available under the brand name Rezdiffra.
- Effective treatment now available to cure hepatitis C
- Effective vaccination to prevent hepatitis B
- How to prevent fatty liver disease (which affects 1/3 of the world population)
- Why alcohol raises your risk of liver disease
About The Ohio State Wexner Medical Center Hepatology Experts:
- A comprehensive and dedicated medical team for liver care
- The lead medical center in central Ohio for management of metabolic dysfunction associated steatosis liver disease (MASLD), related care and research
- Nationally ranked liver transplant program with rapid volume growth